Evidence map›Paper›PMID 39087855›Full record

ReviewEpilepsia2024

Neurocardiac pathologies associated with potassium channelopathies.

Veronica Singh, David S Auerbach

Abstract readReview
In one paragraph

Review in Epilepsia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. RelJournal of translational medicine · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. International journal of molecular sciences · 2025
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Veronica SinghDepartment of Pharmacology, SUNY Upstate Medical University, Syracuse, New York, USA.ORCID https://orcid.org/0009-0008-3335-6384
David S AuerbachDepartment of Pharmacology, SUNY Upstate Medical University, Syracuse, New York, USA.ORCID https://orcid.org/0000-0001-9198-3847

Funding

Development of a Genetic Rabbit Model of Kcnh2-Mediated Epilepsy, SUDEP, & Long QT Syndrome Type 2R61NS133273 · NINDS · UPSTATE MEDICAL UNIVERSITY · PI AUERBACH, DAVID SCOTT · 2023 to 2024
$702k
Development of a Genetic Rabbit Model of Kcnh2-Mediated Epilepsy, SUDEP, & Long QT Syndrome Type 2R33NS133273 · NINDS · UPSTATE MEDICAL UNIVERSITY · PI David Scott Auerbach · 2025 to 2026
$621k
NINDS NIH HHS 1R61NS133273NINDS NIH HHS R33 NS133273NINDS NIH HHS R61 NS133273
6 · The paper itself

Abstract

Voltage-gated potassium channels are expressed throughout the human body and are essential for physiological functions. These include delayed rectifiers, A-type channels, outward rectifiers, and inward rectifiers. They impact electrical function in the heart (repolarization) and brain (repolarization and stabilization of the resting membrane potential). KCNQx and KCNHx encode K

Indexed as

ChannelopathiesEpilepsyAnimalsDeath, Sudden, CardiacHeart DiseasesHumansPotassium Channels, Voltage-GatedSudden Unexpected Death in EpilepsyPotassium Channels, Voltage-Gatedarrhythmiaepilepsyion channelopathylong QT syndromepotassium channelSUDEP

Identifiers

PMID39087855
PMCPMC11702590

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.